Class of 2026
For invaluable contributions to pediatric cancer research, including discovering tumor-suppressive roles of SMARCB1/SNF5 in malignant rhabdoid tumors, mechanistic definition of SWI/SNF mutations in enhancer dysregulation and aberrant lineage specification, and identifying targeted dependencies and synthetic vulnerabilities in SWI/SNF-mutant cancers.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]